Dr Reddy's won Brazilian approval from ANVISA for generic semaglutide injection for type 2 diabetes, to launch with partner Ache.
Legal · Finvezto · 5 Nov 2026 · Dr. Reddy's Laboratories (DRREDDY)
What happened
Dr Reddy's won Brazilian approval from ANVISA for generic semaglutide injection for type 2 diabetes, to launch with partner Ache. Source: Stock note
Why it matters
Anand Ganapathy K: The company puts Brazil's semaglutide diabetes market at about USD 244.6 million, though several rival generics are already approved there. Source: Stock note
Links
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.